Press Releases

Featured Press Releases

BIO Applauds Farm Bill Progress, Calls for …

BIO commends the leaders and members of the House and Senate Agriculture Committees on their persistence and dedication toward passing a new farm bill this year. The farm bill is vital policy that benefits all Americans, including nutrition programs…

Learn more

BIO Statement Re Updated GREET Model to Measure…

The following statement may be attributed to Beth Ellikidis, BIO's Vice President for Agriculture & Environment: “Today’s release of an updated methodology to qualify crop-based sustainable aviation fuel (SAF) for federal tax credits is a…

Learn more

Admiral William McRaven to Keynote 2024 BIO…

Retired U.S. Navy (SEAL) Four-Star Admiral and the Former Chancellor of The University of Texas System, William McRaven, to Discuss Leadership, Global Events, and the National Security Importance of Biotechnology with BIO CEO, John Crowley …

Learn more

New Criteria Set for Political Contributions from BIO

January 26, 2021

The Biotechnology Innovation Organization announced today that it will resume political giving under new criteria for political leaders seeking campaign assistance. Shortly after the violent demonstration three weeks ago at the US Capitol BIO…

BIO Welcomes U.S. Involvement in COVAX, ACT Accelerator Programs

January 21, 2021

The Biden administration just announced its intent for the United States to join the COVAX vaccine facility, which aims to deliver COVID-19 vaccines to poor and under-developed countries. Dr. Michelle McMurry-Heath, president and CEO of the…

BIO and LCFC Support New Mexico Governor's Vision to Address Climate Change Through Clean Fuel Standard

January 20, 2021

Washington, D.C. (January 20, 2021) — The BiotechnologyInnovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) today released the following statement in support of New Mexico Governor Michelle Lujan Grisham’s inclusion of a…

BIO Condemns Trump Administration's Last-ditch Effort To Strip Critical Medicare Part D Protections

January 20, 2021

In his last day in office, former President Donald Trump proposed a sweeping change to Medicare’s “Part D” drug benefit. Billed as a demonstration project through the Centers for Medicare and Medicaid Innovation (CMMI), this new policy would allow…

BIO Congratulates President Biden and Vice President Harris on "Historic Inauguration"

January 20, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO) made the following remarks after President Joe Biden and Vice President Kamala Harris were sworn into office: “On behalf of the Biotechnology…

Biotechnology’s Leading Trade Group Restructures for the Future

January 19, 2021

Washington, DC – The Biotechnology Innovation Organization (BIO), which announced its transition to a new CEO in June to Dr. Michelle McMurry-Heath, is announcing a new leadership team and organizational structure that promises to provide long…

BIO Applauds Incoming Administration's Decision Elevating Key White House Science Post to Cabinet-level Agency

January 16, 2021

President-elect Joe Biden announced on Friday a plan to make the White House Office of Science and Technology Policy a Cabinet-level agency. Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the…

Trump Administration Move to Issue RFS Waivers "Beyond Egregious"

January 12, 2021

Stephanie Batchelor, vice president of BIO's Industrial and Environmental Section, released the following statement in reaction to the Trump administration's move to issue Renewable Fuel Standard (RFS) waivers for the 2019 compliance year. “This…

BIO Releases Statement Concerning Future Political Giving

January 11, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions: "As of today BIO will be pausing our political giving so we can…

BIO Statement on CMS' Approval of TennCare Medicaid Waiver

January 11, 2021

Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.